This is the authors' abstract. We don't add key points for this paper.
The usage of robotic surgery in rectal cancer (RC) is increasing, but there is an ongoing debate as to whether it provides any benefit. This study conducted a meta-analysis of rectal cancer surgery for short-term and long-term outcome by Robotic and robotic-assisted surgery (RS) vs laparoscopic surgery (LS).Pubmed, Embase, Ovid, CNKI, Cochrane Library and Web of Science databases were searched. Studies clearly documenting a comparison of short-term and long-term effect between RS and LS for RC were selected. Lymph node harvested, operation time, hospital stay, circumferential resection margins(CRM), complications, 3-year disease-free survival (DFS) and 5-year DFS parameters were evaluated. All data were performed by Review Manager 5.3 software. Nine studies were collected that included 1436 cases in total, 716 (49.86%) in the RS group, 720(50.14%) in the LS group. Compared with LS, RS was associated with longer operation time (MD 35.19, 95%CI [7.57, 62.81]; P = 0.01), but similar hospital stay (MD -0.43, 95%CI [-0.87,0.01]; P = 0.05).Lymph node harvested, CRM, complications, 3-year DFS, 5-year DFS had no significance difference between RS and LS groups(MD -0.67,95%CI[-1.53,0.19];P = 0.13;MD 0.86,95%CI[0.54,1.37];P = 0.52;MD 0.97,95%CI [0.73,1.29];P = 0.86;MD 0.94,95%CI[0.60,1.48];P = 0.79;MD 0.88,95%CI[0.52,1.47];P = 0.61 respectively).RS is feasible and safe for RC. It has an advantage in short -term outcome and a similar effect in long-term outcome compared with LS.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Tong et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: